Intrinsic Value
ANI PHARMACEUTICALS INC · ANIP
Conservative
More adverse but historically defensible assumptions.
$1.48
Base
The model's central intrinsic-value estimate.
$21.95
Optimistic
More favorable but historically defensible assumptions.
$97.77
Scenarios are the same model run under different but historically defensible assumptions. They are not price targets. Where a valuation gap is shown it is a comparison with a recent close, not a forecast return; where the price is stale, no gap is shown at all.
Model confidence: 70%Valuation as of Sep 21, 2026Latest filing used Feb 27, 2026
Confidence reflects data completeness, accounting quality, and model reliability. It is not a probability of future price.
Valuation drivers
- Normalized operating margin
- 8.8%
- Normalized NOPAT margin
- 7.2%
- Revenue growth
- 26.2%
- WACC
- 7.49%
- Terminal growth
- 2.50%
- Reinvestment method
- capital turnover
- Terminal-value share
- 350.2%
Model notes (4)
- Terminal value is 350% of enterprise value (Base case)
- Terminal value is 1477% of enterprise value (Conservative case)
- Terminal value is 160% of enterprise value (Optimistic case)
- Minority interest not reported
Model details
- Normalization
- V1
- Scenario
- V2
- Confidence
- V1
- Engine version
- valuation-1.0.1-share-units-terminal
- Data snapshot
- filed:2026-02-27